Search results

Discover four key topics to expect to cover during your first meeting with a contract research organization, to set yourself up for a long-lasting partnership.

Issue 41 of The Altascientist explores immunomodulators, bioanalytical methods, and their biomarkers. Learn about immunotherapy trials and their PK/PD endpoints.

Early-phase drug development is a complex process. Discover how Altasciences, as an integrated CRO/CDMO, alleviates the challenges and reduces risks.

Delve into the core of pharmacokinetics, pharmacodynamics, and toxicokinetics with Altasciences. Uncover the intricate relations that drive drug discovery and development with an engaging exploration.